Here are relevant reports on : breast-cancer-diagnostics-market
-
Malaria Diagnostics Market by Technology (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests), End User (Hospitals, Clinics, Diagnostics Centers, and Others), and Geography - Global Forecast to 2027
The global malaria diagnostics market size is projected to reach USD 1.02 Billion by 2027 from USD 770.5 million in 2022, at a CAGR of 5.4% during the forecast period. Market is driven by factors such as rise in the prevalence of malaria in developing countries. Moreover, the surge in awareness initiatives by governments and the increase in research for new malaria diagnostics are the factors that boost the growth of this market. However, lack of alertness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Preventive Diagnostics Market for Substation Equipment by Diagnostics Type (Partial Discharge, Dissolved Gas Analysis & Oil-Gas, Thermal/Infrared, Insulating Gas Condition, Bushing, Mechanical, Vibration, & Acoustic Condition) - Forecast to 2036
The preventive diagnostic market for substation equipment is projected to reach USD 3.46 billion by 2036 from USD 1.91 billion in 2026, at a CAGR of 6.1%. The preventive diagnostic market for substation equipment includes many major players, including Siemens Energy (Germany), GE Vernova (US), ABB (Switzerland), Hitachi Energy Ltd (Switzerland), Schneider Electric (France), Qualitrol Company LLC (US), Doble Engineering Company (US), OMICRON (Austria), Rugged Monitoring (Canada), and Dynamic Ratings (US).
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Middle East & Africa molecular diagnostics market, valued at USD 0.32 billion in 2025, stood at USD 0.33 billion in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of USD 0.47 billion by the end of the period.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Asia Pacific molecular diagnostics market, valued at US$3.85 billion in 2025, stood at US$4.22 billion in 2026 and is projected to advance at a resilient CAGR of 12.4% from 2026 to 2031, culminating in a forecasted valuation of US$7.58 billion by the end of the period. The Asia Pacific molecular diagnostics market is experiencing significant growth as healthcare systems across the region are increasingly focusing on enhancing the accuracy of diagnosis and increasing access to diagnostic testing.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
US Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The US molecular diagnostics market, valued at US$8.34 billion in 2025, stood at US$8.93 billion in 2026 and is projected to advance at a resilient CAGR of 9.9% from 2026 to 2031, culminating in a forecasted valuation of US$14.32 billion by the end of the period. The growing use of molecular tests for early diagnosis, treatment selection, and disease monitoring, along with the wider adoption of personalized medicine, is further supporting demand.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Europe Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Europe molecular diagnostics market, valued at US$5.60 billion in 2025, stood at US$6.05 billion in 2026 and is projected to advance at a resilient CAGR of 10.9% from 2026 to 2031, culminating in a forecasted valuation of US$10.15 billion by the end of the period.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030
The global molecular diagnostics market, valued at USD 18.29 billion in 2024, stood at USD 19.48 billion in 2025 and is projected to advance at a resilient CAGR of 9.6% from 2025 to 2030, culminating in a forecasted valuation of USD 30.74 billion by the end of the period. The Asia Pacific market is projected to register the highest CAGR during the forecast period, primarily due to the increasing healthcare expenditure and rapid expansion of medical infrastructure in Asia Pacific countries.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Latin America Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Latin America molecular diagnostics market, valued at US$0.72 billion in 2025, stood at US$0.76 billion in 2026 and is projected to advance at a resilient CAGR of 8.8% from 2026 to 2031, culminating in a forecasted valuation of US$1.16 billion by the end of the period. This growth can be attributed to the rising demand for reliable diagnostic results, especially in infectious diseases & chronic illnesses like cancer.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Global Colorectal Cancer Market (2010-2015)
2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast)
Prostate cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost.
- Published: November 2011
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
